Category: Oncology/Hematology
Middle East Oncology/Hematology
-
Global & Saudi Arabia Cancer Therapeutics Market to 2031
... related mortality rates. According to GLOBOCAN 2020, approximately 27,885 new cancer cases were reported, with projections indicating a rise to 60,429 cases by 2040. The report Rights and Wellbeing of Older Persons in Saudi Arabia ... Read More
-
Global & Bahrain Cancer Therapeutics Market to 2031
... predispositions contribute to the expected increase in cancer incidence in the country. Key risk factors for colorectal cancer include obesity, sedentary behavior, smoking, and diets high in fat but low in fiber, with nearly one-third ... Read More
-
Global & Kuwait Cancer Therapeutics Market to 2031
... 20.5% of all diagnosed cancers. The five-year prevalence rate for breast cancer across all age groups stood at 211.30 per 100,000 people. It was also the leading cause of cancer-related deaths among women in Kuwait, ... Read More
-
Global & Oman Cancer Therapeutics Market to 2031
... is an increasing demand for effective treatment options, driving growth in the cancer therapeutics market. Oman’s Ministry of Health (MOH) has been actively working to strengthen the healthcare system, particularly in oncology. Key institutions such ... Read More
-
Global & United Arab Emirates Cancer Therapeutics Market to 2031
... In the federal budget for 2022, 8.4% of the government’s approved public spending—totaling US$15.8 billion (AED 58.931 billion)—was allocated to the healthcare sector. The UAE government remains the primary financier of its healthcare system and ... Read More
-
Global & Qatar Cancer Therapeutics Market to 2031
... The increasing number of cancer diagnoses has led to greater emphasis on advanced treatment options, including immunotherapy and targeted therapies. Healthcare is a priority for Qatar’s government under its National Vision 2030, which aims to ... Read More
-
Middle East Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and Middle East Cancer Therapeutics Market Analysis: The cancer therapeutics market in Middle East is experiencing significant growth driven by several key factors, including significant advancements in healthcare infrastructure and an increase in the ... Read More
-
Middle East and Africa Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and Middle East and Africa Cancer Therapeutics Market Analysis: The Middle East and Africa (MEA) cancer therapeutics market is set to experience long-term and high-growth development over the next decade. This is being driven ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience. With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained ... Read More
-
Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, and Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to the increasing applications ... Read More
-
Fecal Calprotectin Test Market, By Assay Type (Enzyme Linked Immunosorbent Assay (ELISA), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography), By Indication (Inflammatory Bowel Disease (IBD) Diagnosis, Colorectal Cancer, Celiac Disease, and others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and others), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... making it a helpful biomarker for identifying and tracking the condition. Market Dynamics: The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of ... Read More
-
Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
... of 12.3% from 2023 to 2031. Integration of Artificial Intelligence and Machine Learning with ePROS Platforms Bolsters Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market EPRO platforms integrate artificial intelligence (AI) and machine learning ... Read More
-
Middle East & Africa Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... 4.5% from 2023 to 2031. Integration of Artificial Intelligence (AI) and Automation Technologies Bolster Middle East & Africa Transient Protein Expression Market The integration of artificial intelligence (AI) and automation technologies into transient protein expression ... Read More
-
CAR T Cell Therapy Market, By Targeted Antigen (CD19, BCMA, HER2, GD2, CD20, CD22, CD30, CD33, HER1, Others (CLDN18, etc.)), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... altering in T cells. For chimeric antigen receptor (CAR)-T cell therapy, T cells are extracted from human body using a procedure called leukapheresis. Then after extraction, T cells are altered by adding the gene for ... Read More
-
2025 Qatar Molecular Diagnostics Market: 2024 Supplier Shares, Analyzer Installed Base and Strategies, 2024-2029 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... or marketing new technologies and products for major tests. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher/Cepheid Becton Dickinson Biokit bioMerieux Bio-Rad Decode Genetics Diasorin Eiken ... Read More
-
2025 Jordan Molecular Diagnostics Market: 2024 Supplier Shares, Analyzer Installed Base and Strategies, 2024-2029 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... or marketing new technologies and products for major tests. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher/Cepheid Becton Dickinson Biokit bioMerieux Bio-Rad Decode Genetics Diasorin Eiken ... Read More
-
2025 Oman Molecular Diagnostics Market: 2024 Supplier Shares, Analyzer Installed Base and Strategies, 2024-2029 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... or marketing new technologies and products for major tests. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher/Cepheid Becton Dickinson Biokit bioMerieux Bio-Rad Decode Genetics Diasorin Eiken ... Read More
-
Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal ... Read More
-
Cell Therapy Market, By Therapy Type (Stem Cells, T-cells, Dendritic Cells, NK-cells), By Indication (Oncology, Cardiology, Neurology, Others), By End User (Hospitals, Clinics, Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to witness growth substantially over the next decade due to rising prevalence of chronic diseases coupled with increasing geriatric population globally. Cell therapy is an emerging and promising field that works with living cells to ... Read More
-
PEGylated Drugs Market Research Report Information by Molecule (Macromolecular Drugs, Small Molecular Drugs and Lipid Nanoparticles (LNP) and Liposomes), by Application (Oncology, Neurology, Autoimmune Diseases, Haematology and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) Industry Forecast till 2035
... fragments, enzymes, and oligonucleotides, to covalent and non-covalent glycol polymer chains. It is a secure technique that is employed to enhance the therapeutic efficacy of medications in a clinical setting. Numerous pegylated pharmaceuticals have been ... Read More
-
Elderly Nutrition Market, By Nutrition Type (Protein, Minerals, Multi-vitamins, Fibers, Lipids, Antioxidants, Iron), By Application (Obesity, Diabetes, Renal Failures, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... dietary habits and malnutrition among elderly people can increase the risk of chronic diseases and faster cognitive decline. There has been huge demand for fortified food products that provides essential nutrients, vitamins, minerals, and protein ... Read More
-
2025 Qatar Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Iraq Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Jordan Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Lebanon Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
Research Assistance
